Is a complete CSE/CDVA research report available?

No complete published report is available for cse/CDVA (CSE/CDVA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/CDVA (CSE/CDVA)

Canadian Securities Exchange: CSE/CDVA · CAD

CA$0.04

-0.01 (-20.0%)· Recorded snapshot

Market cap	5.3M
Revenue (ttm)	13.7M
Net income (ttm)	-2.6M
EPS (ttm)	-CA$0.02
Volume	1,000
Beta	-0.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.7M
Net income (ttm): -2.6M
EPS (ttm): -CA$0.02
Market cap: 5.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-11 02:00 UTC

All CSE/CDVA indicators

Market & fundamental data

Available fields

178

Groups with data

Currency

CAD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 10.4M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	21.87
Isin	CA21864T1075
Last refreshed	2026-09-11
Market cap	CAD 5.3M
Price	CAD 0.04
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/CDVA
Website	https://www.cordovacann.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-49.62%
EV/EBIT	22.25x
EV/EBITDA	11.29x
EV/FCF	11.49x
EV/Sales	0.77x
FCF yield	17.05%
P/B ratio	-0.92x
P/S ratio	0.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.44%
EBITDA Margin	4.77%
FCF margin	6.61%
Gross margin	27.9%
Gross Profit	CAD 3.8M
Gross Profit Growth	0.54%
Gross Profit Growth Q	-7.13%
Gross Profit Growth3 Y	4.25%
Gross Profit Growth5 Y	11.6%
Net Income	CAD -2.6M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-15.21%
Profit Margin	-19.22%
ROA	3.65
Roa5y	-6.74
ROCE	-14.96
ROIC	21.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.02%
Cagr3y	-39.42%
Cagr5y	-33.82%
EPS Growth Quarters	2
EPS Growth Years	0
FCF Growth	-37.46%
FCF Growth Q	20.63%
FCF Growth Qo Q	22.91%
OCF Growth	-34.62%
OCF Growth Q	20.63%
OCF Growth Qo Q	22.91%
Revenue Growth	-2.84x
Revenue Growth Q	-9.88x
Revenue Growth Qo Q	-12.5x
Revenue Growth Years	5x
Revenue Growth3 Y	1.09x
Revenue Growth5 Y	13.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 1.7
Assets	CAD 6.4M
Cash	CAD 515,151
Current Assets	CAD 1.7M
Current Liabilities	CAD 9.5M
Debt	CAD 5.2M
Debt EBITDA	CAD 5.56
Debt FCF	CAD 5.71
Equity	CAD -5.8M
Interest Coverage	0.95
Liabilities	CAD 12.1M
Long Term Assets	CAD 4.7M
Long Term Liabilities	CAD 2.6M
Net Cash	CAD -4.7M
Net Cash By Market Cap	CAD -87.62
Net Debt EBITDA	CAD 7.12
Net Debt FCF	CAD 5.14
Tangible Book Value	CAD -9.3M
Tangible Book Value Per Share	CAD -0.09
WACC	5.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.18
Inventory Turnover	10.13
Net Working Capital	CAD -5.8M
Quick ratio	0.07
Working Capital	CAD -7.8M
Working Capital Turnover	CAD -1.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50%
200-day SMA	0.1
3Y total return	-77.78%
50-day SMA	0.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-87.3%
All Time High	2
All Time High Change	-98%
All Time High Date	2018-08-21
All Time Low	0.01
All Time Low Change	700%
All Time Low Date	2025-12-29
ATR	0.01
Beta	-0.23
Ch YTD	33.33
High	0.04
High52	0.08
High52 Date	2026-04-23
High52ch	-50%
Low	0.04
Low52	0.01
Low52 Date	2025-12-29
Low52ch	700%
Ma50ch	13.31%
Price vs 200-day SMA	-58.68%
RSI	50.36
RSI Monthly	44.65
RSI Weekly	42.18
Sharpe ratio	1.68x
Sharpe Ratio3y	1.08x
Sortino ratio	4.83
Sortino Ratio3y	2.86
Total Return	-0.09%
Tr YTD	33.33
Tr1m	60%
Tr3m	-27.27%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	98,649,848%
Net Borrowing	-2,135,928
Shares Insiders	6.09%
Shares Institutions	2.68%
Shares Qo Q	0%
Shares Yo Y	0.09%
Short Ratio	0.55

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	16,560.6x
Bv Per Share	-0.06
CAPEX	CAD -16,681
Ch1m	60
Ch1y	-50
Ch3m	-27.27
Ch3y	-77.78
Ch5y	-87.3
Ch6m	60
Change	-20%
Change From Open	0
Close	0.05
Days Gap	-20
Depreciation Amortization	182,030
Dollar Volume	40
Earnings Date	2026-10-29
EBIT	CAD 472,505
EBITDA	CAD 654,535
EPS	CAD -0.02
F Score	5
FCF	CAD 906,769
FCF EV Yield	8.7x
Financing CF	-2,485,945
Fiscal Year End	June
Founded	1,997
Income Tax	CAD 334,090
Investing CF	1,548,933
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2026-03-31
Ma150	0.06
Ma150ch	-36.2%
Ma20	0.04
Ma20ch	-4.76%
Net CF	33,668
Next Earnings Date	2026-10-29
Open	0.04
P FCF Ratio	5.86
P OCF Ratio	5.76
Ppne	1,576,786
Price Date	2026-09-10
Price EBITDA	CAD 8.12
Relative Volume	0.06x
Revenue	13,723,380x
Tax By Revenue	2.43x
Tr6m	60%
Volume	1,000
Z Score	-8.58

CSE/CDVA (CSE/CDVA)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/CDVA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/CDVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/CDVA

Frequently asked questions